89 related articles for article (PubMed ID: 22944692)
1. A catalogue of putative HIV-1 protease host cell substrates.
Impens F; Timmerman E; Staes A; Moens K; Ariën KK; Verhasselt B; Vandekerckhove J; Gevaert K
Biol Chem; 2012 Sep; 393(9):915-31. PubMed ID: 22944692
[TBL] [Abstract][Full Text] [Related]
2. Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development.
Beck ZQ; Hervio L; Dawson PE; Elder JH; Madison EL
Virology; 2000 Sep; 274(2):391-401. PubMed ID: 10964781
[TBL] [Abstract][Full Text] [Related]
3. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
[TBL] [Abstract][Full Text] [Related]
4. Effect of HIV constructs containing protease-reverse transcriptase fusion proteins on viral replication.
Cherry E; Morin N; Wainberg MA
AIDS; 1998 Jun; 12(9):967-75. PubMed ID: 9662192
[TBL] [Abstract][Full Text] [Related]
5. A heterologous substrate assay for the HIV-1 protease engineered in Escherichia coli.
Stebbins J; Deckman IC; Richardson SB; Debouck C
Anal Biochem; 1996 Nov; 242(1):90-4. PubMed ID: 8923970
[TBL] [Abstract][Full Text] [Related]
6. Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors.
Friedler A; Blumenzweig I; Baraz L; Steinitz M; Kotler M; Gilon C
J Mol Biol; 1999 Mar; 287(1):93-101. PubMed ID: 10074409
[TBL] [Abstract][Full Text] [Related]
7. In vitro processing of HIV-1 nucleocapsid protein by the viral proteinase: effects of amino acid substitutions at the scissile bond in the proximal zinc finger sequence.
Tözsér J; Shulenin S; Louis JM; Copeland TD; Oroszlan S
Biochemistry; 2004 Apr; 43(14):4304-12. PubMed ID: 15065874
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase.
Welker R; Kottler H; Kalbitzer HR; Kräusslich HG
Virology; 1996 May; 219(1):228-36. PubMed ID: 8623533
[TBL] [Abstract][Full Text] [Related]
9. A side chain at position 48 of the human immunodeficiency virus type-1 protease flap provides an additional specificity determinant.
Moody MD; Pettit SC; Shao W; Everitt L; Loeb DD; Hutchison CA; Swanstrom R
Virology; 1995 Mar; 207(2):475-85. PubMed ID: 7886951
[TBL] [Abstract][Full Text] [Related]
10. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
[TBL] [Abstract][Full Text] [Related]
11. Computational proteomics analysis of HIV-1 protease interactome.
Kontijevskis A; Wikberg JE; Komorowski J
Proteins; 2007 Jul; 68(1):305-12. PubMed ID: 17427231
[TBL] [Abstract][Full Text] [Related]
12. In vitro cleavage of eIF4GI but not eIF4GII by HIV-1 protease and its effects on translation in the rabbit reticulocyte lysate system.
Ohlmann T; Prévôt D; Décimo D; Roux F; Garin J; Morley SJ; Darlix JL
J Mol Biol; 2002 Apr; 318(1):9-20. PubMed ID: 12054764
[TBL] [Abstract][Full Text] [Related]
13. Predicting human immunodeficiency virus protease cleavage sites in proteins by a discriminant function method.
Chou KC; Tomasselli AG; Reardon IM; Heinrikson RL
Proteins; 1996 Jan; 24(1):51-72. PubMed ID: 8628733
[TBL] [Abstract][Full Text] [Related]
14. An E. coli expression system which detoxifies the HIV protease.
Korant BD; Rizzo CJ
Biomed Biochim Acta; 1991; 50(4-6):643-6. PubMed ID: 1801736
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human immunodeficiency virus type 1 (HIV-1) containing mutations in the nucleocapsid protein at a putative HIV-1 protease cleavage site.
Thomas JA; Shulenin S; Coren LV; Bosche WJ; Gagliardi TD; Gorelick RJ; Oroszlan S
Virology; 2006 Oct; 354(2):261-70. PubMed ID: 16904152
[TBL] [Abstract][Full Text] [Related]
16. Protein promiscuity: drug resistance and native functions--HIV-1 case.
Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
[TBL] [Abstract][Full Text] [Related]
17. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
Wu X; Liu H; Xiao H; Kappes JC
Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
[TBL] [Abstract][Full Text] [Related]
18. Comparative properties of feline immunodeficiency virus (FIV) and human immunodeficiency virus type 1 (HIV-1) proteinases prepared by total chemical synthesis.
Schnölzer M; Rackwitz HR; Gustchina A; Laco GS; Wlodawer A; Elder JH; Kent SB
Virology; 1996 Oct; 224(1):268-75. PubMed ID: 8862421
[TBL] [Abstract][Full Text] [Related]
19. Substrate recognition in HIV-1 protease: a computational study.
Perez MA; Fernandes PA; Ramos MJ
J Phys Chem B; 2010 Feb; 114(7):2525-32. PubMed ID: 20121080
[TBL] [Abstract][Full Text] [Related]
20. Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins.
Cherry E; Liang C; Rong L; Quan Y; Inouye P; Li X; Morin N; Kotler M; Wainberg MA
J Mol Biol; 1998 Nov; 284(1):43-56. PubMed ID: 9811541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
